CClinicalTrials.gg
CompletedNCT05119946Updated Nov 15, 2021

A Feasibility Study of a Suicide Prevention Video

An interventional study of Suicide prevention video and Standard suicide treatment in Suicidal Ideation, Suicide Attempts and Psychiatric Illness, sponsored by Fraser Health. Completed at 1 site in Canada. Open to participants aged 19 Years and older. Per ClinicalTrials.gov, last updated 2021-11-15.

Sponsored by Fraser Health · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
19 Years and older
Sex
All
01

Study summary

This initial study is a pilot feasibility study with a primary objective of assessing the feasibility of a larger study by evaluating the procedures and methodology, as well as collecting pilot data. The eventual research goal is to demonstrate whether a suicide prevention video in addition to standard care for suicidality is an effective strategy to reduce suicidal behaviours in individuals with a history of such. The suicide prevention video is developed as an educational tool to inform participants of the various consequences of suicide as well as giving a message of hope. It is hoped that such an approach will help to reduce future suicidal behaviours in those who have a history of such. If so, then this could be made as a part of the standard of care in treating patients with suicidality.

Read the detailed description

This pilot study will assess the study procedures and methodology to determine the feasibility of a larger study that will be done to asses for any difference in suicidal behaviours when the suicide prevention video is used in addition to standard of care. As such, the primary objectives will include:

  • Testing of recruitment, retention, consent, and assignment procedures
  • Validating the inclusion/exclusion criteria
  • Determining the acceptability and safety of the proposed intervention
  • Evaluating implementation procedures and methodology for the intervention
  • Evaluating the appropriateness of timing and frequency of data collection points
  • Evaluating the appropriateness and feasibility of the assessment tools
  • Obtaining parameters for sample size estimation for the larger study
  • Assessing the effectiveness of the video medium, content in the video and length of the video
02

Conditions studied

  • Suicidal Ideation
  • Suicide Attempts
  • Psychiatric Illness
03

In context

Suicide

701 studies on the registry are indexed under Suicide; 183 are open to participants now.

This study's enrollment of 60 is below the median of 104 across 560 interventional studies indexed under Suicide.

Browse Suicide studies →

Lead sponsor

Fraser Health is the lead sponsor of 36 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
19 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age 19 years or older
  • Admitted to the Royal Columbian Hospital under psychiatric services
  • Individuals will have had suicidal behaviours as part of their presentation leading to hospitalization
  • Individuals must be at the level 2 observation privileges or higher
  • Individuals must be capable of giving consent to participate in the study
  • Individuals must speak and read English fluently Individuals admitted to the hospital as voluntary and involuntary (certified) patients

Exclusion criteria

Exclusion Criteria:

  • Individuals with hearing or visual deficits that impairs hearing or viewing the SPV
  • Individuals who are under the influence of drugs, such as intoxication or active withdrawal
  • Individuals with established diagnoses of cognitive impairment affecting their ability to give consent, understand what is expected of them in the study or follow directions
  • Patients that require a substitute decision makers to provide consent
  • Individuals whose behaviors an/or cognition are actively affected by ongoing psychosis, including hallucinations, delusions, and disorganized behaviors
  • Individuals whose treating team assess them as likely to have a negative response to the SPV, for example paranoia around electronic devices
  • Patient's who's attending physiatrist is one of the study team members
  • Patients who are currently under the direct care of any of the investigators Patients that had acute suicidality in the last 24 hours
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (actual)

Study arms

  • Experimental
    Suicide prevention video

    In this group, in addition to receiving the standard of care for their suicidality, the participants will also view a suicide prevention video.

    Behavioral: Suicide prevention video · Other: Standard suicide treatment

  • Active comparator
    Standard suicide treatment

    In this group, participants will only receive the standard of care for their suicidality, which can include medications and/or therapy. The care will be determine by their attending physician.

    Other: Standard suicide treatment

Interventions

  • BehavioralSuicide prevention video

    The video has been developed by the research team as an educational tool to teach patients about suicide, the consequences of such and imparting a message of hope.

  • OtherStandard suicide treatment

    The standard suicide treatment will be determine by the attending physician and can include medications and/or psychotherapy

06

What researchers measure

Primary outcomes

  1. An assessment of suicidal behaviours following the use of a video intervention

    To assess the change in suicidality of patients admitted for such using the Modified Scale for Suicidal Ideation after being given an educational video explaining common misinformation about suicide.

    Time frame: 12 months

Secondary outcomes

  1. Mean change from baseline in the expression of suicidal ideation on the Modified Scale for Suicidal Ideation at 48 hours, 3 months and 6 months

    To measure the change in suicidal behaviours after viewing the video using the "The Modified Scale for Suicidal Ideation". The scale is used to assess the presence or absence of suicide ideation and the degree of severity of suicidal ideas. The benefit of this scale is that it was developed so that paraprofessionals could administer the scale, yet demonstrated excellent internal consistency and interrater reliability, correlated highly with clinician's ratings of suicidal ideation and risk, and discriminated between suicide attempters and nonattempters prior to hospitalization. The scale would be administered at baseline, after watching the video and at 3 and 6 months after watching the video. Each question is scored for a total score that is interpreted as degree of suicidal ideation. Total score range is 0 to 54. Higher scores indicate more severe suicidal ideations. Changes in the total scores will be analyzed.

    Time frame: 12 months

07

Study locations

1 site
  • Royal Columbian and Eagle Ridge Hospitals
    New Westminster, British Columbia, Canada
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 15, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05119946
Lead sponsor
Fraser Health
Responsible party
Sponsor
First posted
Nov 15, 2021
Start date
Jan 2017
Primary completion
Jun 2020
Completion
Jun 2020
Last update
Nov 15, 2021

Study contacts

Hem Phaterpekar, MD
principal investigator · Fraser Health

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion